Literature DB >> 16048272

Sclerosing peritonitis: a nosological entity.

Guido Garosi1, Nicola Di Paolo, Giovanni Sacchi, Enzo Gaggiotti.   

Abstract

The peritoneal histology of 224 peritoneal dialysis (PD) patients without sclerosing peritonitis (SP) and of 39 PD patients with SP was evaluated. Of the 224 patients, 180 showed simple sclerosis (SS). In these subjects, slight thickness of sclerosis (10 - 70 microm), slight parvicellular infiltration (5/180), slight arterial thickening with no vessel occlusion (19/180), and slight tissue calcification (1/180) were observed. In the 39 patients with SP, striking histological changes versus SS were detected: thickness of sclerosis 250 - 4000 microm, p < 0.01; inflammation 39/39, p < 0.01 (parvicellular infiltration 36/39, p < 0.01; microabscesses 15/39, p < 0.05; giant cells 38/39, p < 0.01; granulation tissue 38/39, p < 0.01); arterial alterations 39/39, p < 0.01 (thickening 39/39, p < 0.01; occlusion 39/39, p < 0.01; calcification 26/39, p < 0.01; ossification 9/39, p < 0.01); tissue calcification 12/39, p < 0.01 (with ossification 4/39, with bone marrow 2/39). The thickness of sclerosis in SS was higher in parietal (30 - 70 microm) than in visceral peritoneum (10 - 40 microm, p < 0.05); in SP it was higher in visceral (600 - 4000 microm) than in parietal peritoneum (250 - 2000 microm, p < 0.05). These striking differences suggest consideration of SS and SP as two separate nosological entities. Differences in frequency, animal models, etiology, and clinical impact seem to confirm this hypothesis, showing that SP is not just the evolution of SS.

Entities:  

Mesh:

Year:  2005        PMID: 16048272

Source DB:  PubMed          Journal:  Perit Dial Int        ISSN: 0896-8608            Impact factor:   1.756


  10 in total

1.  No need for an "expiry date" in chronic peritoneal dialysis to prevent encapsulating peritoneal sclerosis.

Authors:  Guido Garosi; Dimitrios G Oreopoulos
Journal:  Int Urol Nephrol       Date:  2009-12       Impact factor: 2.370

Review 2.  Encapsulating peritoneal sclerosis: the state of affairs.

Authors:  Mario R Korte; Denise E Sampimon; Michiel G H Betjes; Raymond T Krediet
Journal:  Nat Rev Nephrol       Date:  2011-08-02       Impact factor: 28.314

3.  Peritoneal cocoon capsulotomy--an alternative surgical approach in treating encapsulating peritoneal sclerosis.

Authors:  Marc Gingell-Littlejohn; Faisal Hanif; Brian Junor; Marc Clancy; Enric Murio
Journal:  Perit Dial Int       Date:  2013 May-Jun       Impact factor: 1.756

4.  m-TOR inhibitors may be useful in the treatment of encapsulating peritoneal sclerosis (EPS).

Authors:  Giovanni Maria Frascà; Mario D'Arezzo; Anna Maria Ricciatti; Emilio Balestra; Domenica Taruscia; Valentina Nastasi; Gaia Goteri
Journal:  J Nephrol       Date:  2014-02-12       Impact factor: 3.902

5.  Histological criteria for encapsulating peritoneal sclerosis - a standardized approach.

Authors:  Niko Braun; Peter Fritz; Christoph Ulmer; Joerg Latus; Martin Kimmel; Dagmar Biegger; German Ott; Fabian Reimold; Klaus-Peter Thon; Juergen Dippon; Stephan Segerer; M Dominik Alscher
Journal:  PLoS One       Date:  2012-11-07       Impact factor: 3.240

Review 6.  Protective measures against ultrafiltration failure in peritoneal dialysis patients.

Authors:  Anna Rita Aguirre; Hugo Abensur
Journal:  Clinics (Sao Paulo)       Date:  2011       Impact factor: 2.365

Review 7.  Encapsulating peritoneal sclerosis-a rare but devastating peritoneal disease.

Authors:  Zia Moinuddin; Angela Summers; David Van Dellen; Titus Augustine; Sarah E Herrick
Journal:  Front Physiol       Date:  2015-01-05       Impact factor: 4.566

8.  Adhesive intestinal obstruction increases the risk of intestinal perforation in peritoneal dialysis patients: a case report.

Authors:  Kentaro Fujii; Naoki Washida; Eri Arai; Masashi Tsuruta; Shu Wakino; Hiroshi Itoh
Journal:  BMC Nephrol       Date:  2018-06-28       Impact factor: 2.388

9.  Histological and clinical findings in patients with post-transplantation and classical encapsulating peritoneal sclerosis: a European multicenter study.

Authors:  Joerg Latus; Sayed M Habib; Daniel Kitterer; Mario R Korte; Christoph Ulmer; Peter Fritz; Simon Davies; Mark Lambie; M Dominik Alscher; Michiel G H Betjes; Stephan Segerer; Niko Braun
Journal:  PLoS One       Date:  2014-08-29       Impact factor: 3.240

Review 10.  Molecular Mechanisms Underlying Peritoneal EMT and Fibrosis.

Authors:  Raffaele Strippoli; Roberto Moreno-Vicente; Cecilia Battistelli; Carla Cicchini; Valeria Noce; Laura Amicone; Alessandra Marchetti; Miguel Angel Del Pozo; Marco Tripodi
Journal:  Stem Cells Int       Date:  2016-01-31       Impact factor: 5.443

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.